| Literature DB >> 33765256 |
Hideaki Saito1, Hiroaki Miyoshi2, Hirohiko Shibayama3, Jun Toda1, Shinsuke Kusakabe1, Michiko Ichii1, Jiro Fujita1, Kentaro Fukushima1, Tetsuo Maeda1,4, Masao Mizuki1, Kenji Oritani5, Masao Seto2, Takafumi Yokota1, Yuzuru Kanakura1,6, Naoki Hosen1, Koichi Ohshima2.
Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening complication of transplantation. In addition to reactivation of Epstein-Barr virus in immunocompromised patients, impaired tumor immunity is suggested to be a risk factor for PTLD. However, it remains unclear whether immune suppressive tumor-infiltrating lymphocytes (TILs) correlate with the occurrence or prognosis of PTLD. We analyzed TILs in 26 patients with PTLD to elucidate the clinicopathological significance of the expression of PD-1 and FoxP3, which are associated with exhausted T-cells and regulatory T-cells (Tregs), respectively. Numbers of PD-1+ TILs in the PTLD specimens were significantly higher in patients who developed PTLD early after transplantation (P = 0.0040), while numbers of FoxP3+ TILs were not (P = 0.184). There was no difference in overall response rate regardless of the expression of PD-1 or FoxP3. FoxP3high patients tended to have a shorter time to progression compared with FoxP3low patients, especially in the case of FoxP3high patients with diffuse large B-cell lymphoma-subtype PTLD (P = 0.011), while PD-1high patients did not. These results suggest that T-cell exhaustion may be mainly associated with PTLD development, while immune suppression by Tregs may be dominant in enhanced progression of PTLD following disease occurrence.Entities:
Keywords: FoxP3; PD-1; PTLD; Tumor-infiltrating lymphocytes
Year: 2021 PMID: 33765256 DOI: 10.1007/s12185-021-03129-3
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490